Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innotech International is a French pharmaceutical company and a key subsidiary of the family-owned Groupe Batteur, specializing in the development and distribution of medicines and medical devices. The company focuses on several core therapeutic areas, including women's health, venous insufficiency, and mineral deficiencies, with a portfolio of well-recognized brands like Pharmatex, Tot'hema, and Polygymax. With a strong international orientation, Innotech exports its products to over 100 countries, maintaining a significant presence in Eastern Europe, Africa, and Southeast Asia. The company operates its own manufacturing sites in France, specifically in Nomexy and Chaumont, ensuring full control over the production chain and adherence to high quality standards. Innotech continues to expand its global footprint through strategic partnerships and a commitment to providing accessible healthcare solutions for everyday pathologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INNOTECH International.